The objective of the present study was to compare the early effects of treatment with
nebivolol and quinapril on the endothelial function in hypertensive patients. A total of 54 …

Aims Nebivolol is a selective β1‐receptor antagonist with vasodilating properties. In patients
with essential hypertension, we tested the hypothesis that nebivolol increases systemic and …

This aim of this study was to evaluate the presence of endothelial dysfunction in patients
with primary hypertension and to determine the usefulness of nebivolol, a selective β …

Aims/hypothesis. Endothelial dysfunction contributes to the development of diabetic vascular
complications. A better understanding of the pathophysiology of endothelial dysfunction in …

Purpose: To investigate the effect and mechanism of nebivolol on aortic remodeling in N-
nitro-l-arginine methyl ester (l-NAME)-induced hypertension. Methods: Male Sprague …

Background. Nitric oxide (NO) deficiency contributes to chronic kidney disease (CKD)
progression and hypertension. The β-blocker, nebivolol (N), also enhances NO production …

Aims/hypothesis Reduced bioavailability of nitric oxide (NO) is a hallmark of diabetes
mellitus-induced vascular complications. In the present study we investigated whether a …

The endothelium is a favourite early target of cardiovascular risk factors and cardiovascular
diseases like hypertension. This key role of the endothelium results from its capacity to …

It is tempting to speculate that increased vasoconstriction and loss of endotheliumdependent
vasodilation might be etiological factors of elevated blood pressure in the insulinresistant …

Arterial stiffness is a key determinant of cardiovascular risk in hypertensive patients. β-
Blockers appear to be less effective than other drugs in improving outcome in hypertensive …